Jaroslaw Janc
Overview
Explore the profile of Jaroslaw Janc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesnik P, Janc J, Biala M, Bartoszewicz M, Lysenko L, Slabisz N
Pathogens
. 2025 Feb;
14(2).
PMID: 40005574
Since the beginning of December 2022, an unusually high number of cases and deaths of Group A (GAS) infections has been reported in many European countries. GAS infection frequently causes...
2.
Wozniak A, Misiag W, Lesnik P, Janc J, Chabowski M
Dent Med Probl
. 2024 Aug;
PMID: 39093555
Background: Coronavirus disease 2019 (COVID-19) quickly reached the pandemic status, with 765.22 million confirmed cases of COVID-19 and 6.92 million COVID-19 deaths reported worldwide by May 2023. Due to its...
3.
Janc J, Slabisz N, Wozniak A, Lysenko L, Chabowski M, Lesnik P
Front Cell Infect Microbiol
. 2024 May;
14:1297312.
PMID: 38690325
Background: During the coronavirus disease 2019 (COVID-19) pandemic, in patients treated for SARS-CoV-2 infection, infections with the bacteria producing New Delhi metallo-B-lactamase (NDM) carbapenemase in the USA, Brazil, Mexico, and...
4.
Slabisz N, Lesnik P, Janc J, Fidut M, Bartoszewicz M, Dudek-Wicher R, et al.
Front Microbiol
. 2024 Apr;
15:1331628.
PMID: 38646622
Background: Due to the growing resistance to routinely used antibiotics, the search for new antibiotics or their combinations with effective inhibitors against multidrug-resistant microorganisms is ongoing. In our study, we...
5.
Janc J, Janc J, Suchanski M, Fidut M, Lesnik P
Sci Rep
. 2024 Apr;
14(1):7829.
PMID: 38570550
The immunotropic effects of aldosterone might play a role in COVID-19, as SARS-CoV-2 reportedly uses angiotensin-converting enzyme 2 receptors as an entry point into cells. Aldosterone function is closely linked...
6.
Wozniak A, Janc J, Lysenko L, Lesnik P, Slabisz N, Oleksy-Wawrzyniak M, et al.
Int J Med Sci
. 2024 Jan;
21(3):530-539.
PMID: 38250609
Intensive care unit (ICU) patients are at high risk of infection due to multiple invasive procedures, malnutrition, or immunosuppression. The rapid increase in infections with multidrug-resistant organisms (MDRO) during the...
7.
Rosenthal V, Yin R, Nercelles P, Rivera-Molina S, Jyoti S, Dongol R, et al.
Am J Infect Control
. 2024 Jan;
52(9):1002-1011.
PMID: 38185380
Background: Reporting on the International Nosocomial Infection Control Consortium study results from 2015 to 2020, conducted in 630 intensive care units across 123 cities in 45 countries spanning Africa, Asia,...
8.
Rosenthal V, Yin R, Brown E, Lee B, Rodrigues C, Myatra S, et al.
Infect Control Hosp Epidemiol
. 2024 Jan;
45(5):567-575.
PMID: 38173347
Objective: To identify urinary catheter (UC)-associated urinary tract infection (CAUTI) incidence and risk factors. Design: A prospective cohort study. Setting: The study was conducted across 623 ICUs of 224 hospitals...
9.
Rosenthal V, Jin Z, Brown E, Dongol R, De Moros D, Alarcon-Rua J, et al.
Am J Infect Control
. 2023 Dec;
52(5):580-587.
PMID: 38154739
Background: Central line (CL)-associated bloodstream infections (CLABSIs) occurring in the intensive care unit (ICU) are common and associated with a high burden. Methods: We implemented a multidimensional approach, incorporating an...
10.
Rosenthal V, Jin Z, Yin R, Sahu S, Rajhans P, Kharbanda M, et al.
J Crit Care
. 2023 Dec;
80:154500.
PMID: 38128216
Background: Ventilator associated pneumonia (VAP) occurring in the intensive care unit (ICU) are common, costly, and potentially lethal. Methods: We implemented a multidimensional approach and an 8-component bundle in 374...